FTC Bureau of Competition Statement on Termination of Healthcare . . . In response to yesterday’s announcement that Aya Healthcare terminated its proposed acquisition of Cross Country Healthcare, Federal Trade Commission Bureau of Competition Director Daniel Guarnera issued the following statement: “FTC staff identified significant competitive concerns with Aya Healthcare’s proposed acquisition of Cross Country Healthcare The deal would have eliminated
CCRN to Receive $20M Termination Fee as Aya Healthcare Merger. . . Cross Country Healthcare’s anticipated merger with Aya Healthcare was officially terminated after months of regulatory delays, culminating in a $20 million termination fee owed to CCRN by Aya Healthcare The transaction stalled due to a 43-day government shutdown, which extended the critical antitrust review period beyond the agreed-upon